Ann: Update to Integration Agreement Signed with Nexus-Vita, page-19

Yes ok that’s true however this is a speculative stock and company, if you are taking a short term view and using a PE ratio that’s fine but this generally doesn’t apply to speculative stocks.
once the integration is completed and live to the commercial agreements and platforms, we know the PE ratio will decrease substantially, PE ratio shouldn’t come into play as a decision on spec stocks, unless of course it’s way over the top.
The revenue that will be generated with the software that’s patented will rapidly increase the Ebit, Cashflow & MC.


use BRN for example (Brainchip) MC of over $1B, would you utilise a PE ratio on that company? It’s speculative with no real revenue either- your speculating on what could be when it does generate, that’s the point.

if you’re investing into speculative stocks you need to have an open mind and not utilise a PE ratio unless you’re investing in larger proven companies.